3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lung Neoplasms
5
Colorectal Neoplasms
5
Prostatic Neoplasms
3
Hematologic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Motor Activity
2
Lymphoma, Non-Hodgkin
2
Hodgkin Disease
2
Hematopoietic and Lymphoid System Neoplasm
2
Urinary Bladder Neoplasms
1
Small Cell Lung Carcinoma
1
Sleep Wake Disorders
1
Pelvic Neoplasms
1
Pancreatic Neoplasms
1
Obesity
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Melanoma
1
Malignant Solid Neoplasm
1
Malignant Primary Pelvic Neoplasm
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Inflammatory Breast Neoplasms
1
Hematopoietic and Lymphatic System Neoplasm
1
Heart Defects, Congenital
1
Interventions
Oxaliplatin
27
Fluorouracil
23
Leucovorin
22
Cetuximab
22
Bevacizumab
21
Nivolumab
16
Capecitabine
16
Irinotecan
15
pembrolizumab
12
Magnetic Resonance Spectroscopy
11
Specimen Handling
10
encorafenib
8
Folfox protocol
7
trifluridine tipiracil drug combination
6
Ipilimumab
6
Exercise
6
fludarabine
5
cemiplimab
5
Trastuzumab
5
Gemcitabine
5
Cyclophosphamide
5
Cisplatin
5
Blood Specimen Collection
5
Biopsy
5
regorafenib
4
pertuzumab
4
adagrasib
4
Trifluridine
4
Surgical Procedures, Operative
4
Pemetrexed
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Exercise Test
×
1 year
×
Clear all
NCT00819208
2026-04-24
CHALLENGE
Canadian Cancer Trials Group
Phase NA
Completed
889 enrolled
9 charts